Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
β
of holders' portfolios
13F filers
1
institution
52-week range
$1.80 β $4.18
58% from low
No one on the platform currently holds ESPR.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 2,194,600 | $8.1M |
| Execution date | Ratio |
|---|---|
| 2013-06-11 | 1-for-7reverse |
No one on the platform has traded ESPR yet.
No recent Form 4 filings on EDGAR β either no insider transactions reported recently or this isn't a SEC-registered issuer.
Put ticker JUNS onto your watchlist right now! JUNS has only 770k shares outstanding and only 480k shares public float. Look at what SDOT / YXT / DFNS / AKAN did on similar share numbers recently! JUNS has a similar move coming - Added a big position for a squeeze. $ESPR $SPY Long to 800
View on StockTwits β$ESPR Wonder what DJ looks likeβ¦will he be crying in the photo
View on StockTwits β$ESPR Even more accounts deleted. X accounts nuked too, some abandoned from our request. Run, but canβt hide
View on StockTwits β@hsainu Almost like at $ESPR with MGMT sandbagging sales until they got torn a new one
View on StockTwits β$ARDX If anyone wants to know what I mean by creating phantom premium, go look at the $ESPR chart... no one can do Phantom premium like Sheldon, but Raab has probably knocked us back enough that a $9 BO is going to feel glorious, even though the stock could be worth $15-20 in a year or two with proper opex management... stock is now ripe for an activist.
View on StockTwits β$ESPR DS sales were flat last quarter too. Maybe I will chalk this one more up to a potential bullet dodged and less of a golden goose stolen out from under everyone. With some hindsight this is feeling more like a case of massive incompetence on the part of the C suite.
View on StockTwits β$ESPR script growth still looks disappointing. So I guess they havenβt flipped the switch yet. Enbumyst is pathetic, still can barely crack 10 scripts per week. Not holding out much hope for the CVRs.
View on StockTwits βTicker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $ESPR $APP Anyone holding?
View on StockTwits β$ESPR posted this a few days ago my new play
View on StockTwits βRecent $TICKER stream from stocktwits.com β refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $388M | -3.6% | $-0.04 | $-0.05β$-0.03 | β | 2 |
| 2027 | $449M | +15.8% | $0.27 | $0.25β$0.31 | 11.7Γ | 4 |
| 2028 | $505M | +12.4% | $0.43 | $-1.57β$1.57 | 7.4Γ | 3 |
| 2029 | $659M | +30.6% | $0.51 | $0.40β$0.58 | 6.2Γ | 1 |
Forward consensus Β· growth is YoY vs the prior fiscal-year estimate Β· Fwd P/E at the current price Β· source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-08 | $-0.04 | $-0.10 | -150.0% |
| 2026-03-10 | $0.23 | $0.22 | -4.3% |
| 2025-11-06 | $-0.09 | $-0.16 | -77.8% |
| 2025-08-05 | $-0.17 | $-0.02 | +88.2% |
| 2025-05-06 | $-0.18 | $-0.21 | -16.7% |
| 2025-03-04 | $-0.14 | $-0.10 | +28.6% |
| 2024-11-07 | $-0.14 | $-0.15 | -7.1% |
| 2024-08-12 | $-0.15 |
| $-0.05 |
| +66.7% |
| $63M |
| β |
| KPTIKaryopharm Therapeutics Inc. | $1.99 | -1.97% | $45M | β |
| PTCTPTC Therapeutics, Inc. | $71.97 | -0.92% | $6.0B | β |
Source: Financial Modeling Prep Β· peers by sector/industry